202 related articles for article (PubMed ID: 4999088)
1. Production and evaluation of a formalin-killed Chikungunya vaccine.
Harrison VR; Eckels KH; Bartelloni PJ; Hampton C
J Immunol; 1971 Sep; 107(3):643-7. PubMed ID: 4999088
[No Abstract] [Full Text] [Related]
2. Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures.
White A; Berman S; Lowenthal JP
Appl Microbiol; 1972 May; 23(5):951-2. PubMed ID: 4624213
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues.
Harrison VR; Binn LN; Randall R
Am J Trop Med Hyg; 1967 Nov; 16(6):786-91. PubMed ID: 4965219
[No Abstract] [Full Text] [Related]
4. Chikungunya virus vaccine prepared by Tween-ether extraction.
Eckels KH; Harrison VR; Hetrick FM
Appl Microbiol; 1970 Feb; 19(2):321-5. PubMed ID: 4985431
[TBL] [Abstract][Full Text] [Related]
5. Studies on live rubella vaccine. I. Propagation of rubella virus in developing chick embryos and its laboratory characterization.
Okuno Y; Minekawa Y; Suzuki N; Takahashi M
Biken J; 1968 Dec; 11(4):235-42. PubMed ID: 4976546
[No Abstract] [Full Text] [Related]
6. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.
Tiwari M; Parida M; Santhosh SR; Khan M; Dash PK; Rao PV
Vaccine; 2009 Apr; 27(18):2513-22. PubMed ID: 19368794
[TBL] [Abstract][Full Text] [Related]
7. Studies on live attenuated mumps virus vaccine. 1. Attenuation of mumps virus by serial passage in the chorioallantoic cavity of developing chick embryos and field trials by the inhalation method.
Hosai H; Yamanishi K; Ueda S; Minekawa Y; Ogino T
Biken J; 1970 Jun; 13(2):121-6. PubMed ID: 4990327
[No Abstract] [Full Text] [Related]
8. Antibody against Chikungunya virus in wild primates in Southern Africa.
McIntosh BM
S Afr J Med Sci; 1970 Dec; 35(3):65-74. PubMed ID: 4398581
[No Abstract] [Full Text] [Related]
9. Immunogenicity of purified, inactivated chikungunya virus in monkeys.
Nakao E; Hotta S
Bull World Health Organ; 1973 May; 48(5):559-62. PubMed ID: 4204490
[TBL] [Abstract][Full Text] [Related]
10. The experimental production of a formalin-killed Japanese encephalitis virus vaccine from porcine kidney cell cultures.
Inoue YK; Nishibe Y
Arch Gesamte Virusforsch; 1967; 21(2):192-9. PubMed ID: 4298423
[No Abstract] [Full Text] [Related]
11. Contamination of simian viruses in African green monkeys (Cercopithecus aethiops).
Yamane Y; Nagashima T; Takada M; Owada Y; Kasahara S
Kitasato Arch Exp Med; 1969 Jun; 42(1):27-40. PubMed ID: 4992619
[No Abstract] [Full Text] [Related]
12. Studies on Chikungunya virus. II. Purification of mouse brain virus.
Igarashi A; Fukai K; Tuchinda P
Biken J; 1967 Dec; 10(4):189-94. PubMed ID: 5591504
[No Abstract] [Full Text] [Related]
13. Studies on Japanese B encephalitis virus vaccines from tissue culture. 8. Formalin inactivated OCT-wild strain vaccine.
Darwish MA; Hammon WM
J Immunol; 1966 Oct; 97(4):506-11. PubMed ID: 4289222
[No Abstract] [Full Text] [Related]
14. The development of a vaccine for bovine herpes mammillitis.
Rweyemamu MM; Johnson RH
Res Vet Sci; 1969 Sep; 10(5):419-27. PubMed ID: 4311593
[No Abstract] [Full Text] [Related]
15. [Relation between antibody formation and immunity against cutaneous vaccinia virus infection in hens].
Andrzejewski J; Bogunowicz A; Zajac I
Zentralbl Bakteriol Orig; 1968; 207(3):419-21. PubMed ID: 5745681
[No Abstract] [Full Text] [Related]
16. [Evaluation of various methods for determining the potency of fowl pox vaccines].
Szakmáry G
Arch Exp Veterinarmed; 1969 Nov; 23(5):945-61. PubMed ID: 4319654
[No Abstract] [Full Text] [Related]
17. Studies on Japanese B encephalitis virus vaccines from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 2. The characteristics of inactivation of an attenuated strain of OCT-541.
Darwish MA; Hammon WM
J Immunol; 1966 May; 96(5):806-13. PubMed ID: 4288022
[No Abstract] [Full Text] [Related]
18. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
Vasington PJ
Natl Cancer Inst Monogr; 1968 Dec; 29():205-6. PubMed ID: 4976358
[No Abstract] [Full Text] [Related]
19. Industrial production of primary tissue culture.
Warren J
Natl Cancer Inst Monogr; 1968 Dec; 29():35-43. PubMed ID: 4976363
[No Abstract] [Full Text] [Related]
20. Cross-neutralization studies with group C arboviruses.
Karabatsos N; Henderson JR
Acta Virol; 1969 Nov; 13(6):544-8. PubMed ID: 4391723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
